Additionally, CD4-IL15/IL15sushi CAR cells outperformed CD4 CAR cells in vivo, reducing tumor burden and providing survival benefit, suggesting that the secreted IL15/IL15sushi complex may be beneficial in the treatment of T-cell malignancies. The gene discussed is CD4; the disease is neoplasm.